Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Durvalumab in novel combinations for head and neck cancer

Dr Ezra Cohen - UC San Diego Health, San Diego, USA
Durvalumab in novel combinations for head and neck cancer ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )
11 Sep 2017

COMBI-AD: Dabrafenib plus trametinib in advanced melanoma

Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
COMBI-AD: Dabrafenib plus trametinib in advanced melanoma ( Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )
11 Sep 2017

Expert commentary on melanoma immunotherapy latest

Dr Jeffrey Weber, Dr Axel Hauschild, Dr Dummer Reinhard
Expert commentary on melanoma immunotherapy latest ( Dr Jeffrey Weber, Dr Axel Hauschild, Dr Dummer Reinhard )
11 Sep 2017

Vemurafenib for high risk melanoma patients

Dr Karl Lewis - University of Colorado Denver, Colorado, USA
Vemurafenib for high risk melanoma patients ( Dr Karl Lewis - University of Colorado Denver, Colorado, USA )
11 Sep 2017

Dabrafenib plus trametinib for stage III mutant melanoma

Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
Dabrafenib plus trametinib for stage III mutant melanoma ( Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )
11 Sep 2017

Nivolumab vs ipilimumab for high risk melanoma patients

Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA
Nivolumab vs ipilimumab for high risk melanoma patients ( Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA )
11 Sep 2017

Patient perceptions of chemotherapy side effects differ over time and treatment

Dr Beyhan Ataseven - Kliniken Essen-Mitte, Essen, Germany
Patient perceptions of chemotherapy side effects differ over time and treatment ( Dr Beyhan Ataseven - Kliniken Essen-Mitte, Essen, Germany )
10 Sep 2017

ABP 980, a biosimilar antibody for trastuzumab

Dr Richard Markus - Amgen, Conejo Valley, USA
ABP 980, a biosimilar antibody for trastuzumab ( Dr Richard Markus - Amgen, Conejo Valley, USA )
10 Sep 2017

New strategies in melanoma care

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
New strategies in melanoma care ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2017

Real-world productivity of advanced gastric cancer patients

Dr Marta Contente - Bristol-Myers Squibb, Uxbridge, UK
Real-world productivity of advanced gastric cancer patients ( Dr Marta Contente - Bristol-Myers Squibb, Uxbridge, UK )
10 Sep 2017

Abemaciclib for advanced breast cancer

Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy
Abemaciclib for advanced breast cancer ( Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy )
10 Sep 2017

Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer

Dr Evandro de Azambuja - Jules Bordet Institute, Brussels, Belgium
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer ( Dr Evandro de Azambuja - Jules Bordet Institute, Brussels, Belgium )
10 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation